Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D01SWK
|
||||
Former ID |
DIB016776
|
||||
Drug Name |
Rafabegron
|
||||
Synonyms |
AD-9677; AJ-9677; TAK-677
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Type 2 diabetes [ICD9: 250; ICD10:E11] | Discontinued in Phase 2 | [546607] | ||
Company |
Dainippon Pharmaceutical Co Ltd
|
||||
Structure |
Download2D MOL |
||||
Formula |
C21H23ClN2O4
|
||||
Canonical SMILES |
c12c(c(c[nH]2)C[C@H](NC[C@@H](c2cc(ccc2)Cl)O)C)cccc1OCC<br />(=O)O
|
||||
CAS Number |
CAS 244081-42-3
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Beta-3 adrenergic receptor | Target Info | Modulator | [528534] | |
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.